NEVANAC is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Nepafenac.
| Product ID | 0065-0002_01a34750-69f1-4871-b8cf-1f5bc1badfdf |
| NDC | 0065-0002 |
| Product Type | Human Prescription Drug |
| Proprietary Name | NEVANAC |
| Generic Name | Nepafenac |
| Dosage Form | Suspension/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2005-09-06 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021862 |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | NEPAFENAC |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2005-09-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021862 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2005-09-06 |
| Marketing End Date | 2018-02-09 |
| Marketing Category | NDA |
| Application Number | NDA021862 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2005-09-06 |
| Ingredient | Strength |
|---|---|
| NEPAFENAC | 1 mg/mL |
| SPL SET ID: | 3ad48650-75e3-4c74-9302-01b0088f164e |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0065-0002 | NEVANAC | nepafenac |
| 0078-0778 | NEVANAC | nepafenac |
| 0065-1750 | ILEVRO | nepafenac |
| 0078-0743 | ILEVRO | nepafenac |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NEVANAC 78361073 3149473 Live/Registered |
NOVARTIS AG 2004-02-02 |